Ablation for Kidney Cancer: A Less Invasive Treatment Option
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer
Ablation for kidney cancer is an alternative to surgical tumor removal for small kidney tumors, typically under 3 centimeters [1]. A thin probe inserted through the skin or small incisions delivers heat or cold directly to the tumor [1]. It is often recommended for patients who are poor candidates for major surgery or who have multiple small tumors [1].
What the research says
Ablation caused far fewer short-term complications than surgery, with cancer survival similar to radical nephrectomy and slightly lower than partial nephrectomy. In 4,310 adults aged 66 or older treated for T1a kidney cancer (tumors under 4 cm) in a US cancer registry linked to Medicare claims, five-year kidney-cancer-specific survival was 95% after percutaneous ablation versus 98% after partial nephrectomy, and 96% versus 95% after radical nephrectomy. Five-year overall survival was 77% after ablation versus 86% after partial nephrectomy (74% versus 75% for radical nephrectomy). Non-urologic complications within 30 days occurred in 6% of the ablation group versus 29% after partial and 30% after radical nephrectomy. Because the study was observational and healthier patients may have been steered toward partial nephrectomy, the authors cautioned that the results may be affected by selection bias (PubMed: Talenfeld et al., Ann Intern Med, 2018) [2].
Ablation preserved kidney function about as well as partial nephrectomy. A systematic review and meta-analysis of 58 articles found no differences in kidney function outcomes between partial nephrectomy and thermal ablation, while radical nephrectomy carried a higher risk of chronic kidney disease stage 3 or worse than partial nephrectomy (relative risk 2.56; 95% CI 1.97 to 3.32) (PubMed: Patel et al., Clin J Am Soc Nephrol, 2017) [3].
What is ablation for kidney cancer?
Ablation therapy serves as a critical alternative to traditional nephrectomy for individuals diagnosed with renal tumors. The primary goal of this procedure is to destroy abnormal cells through thermal energy while minimizing damage to the surrounding healthy kidney [1]. Unlike radical or partial nephrectomy, which involves significant surgical removal of tissue, ablation focuses on localized cell death guided by real-time imaging [1].
Ablation is a less invasive alternative to surgically removing a tumor. It spares the surrounding healthy kidney tissue, and it can be a good choice for people with other health complications or who prefer to avoid surgery [1].
Types of Ablation Procedures
There are several methods used to achieve thermal destruction of kidney tumors, each utilizing different forms of energy. The choice of method often depends on the tumor's location and the specific equipment available at the medical facility.
Method | Energy Source | Temperature Effect | Also Known As |
Cryoablation | Argon or Helium gas | Extreme Cold (Freezing) [1] | Cryotherapy, Cryosurgery [1] |
Radiofrequency Ablation (RFA) | Radio waves (Electrical) | High Heat [1] | RFA |
Microwave Ablation (MWA) | Electromagnetic waves | High Heat [1] | MWA |
Laser Ablation | Light energy | High Heat [1] | Laser therapy |
What are the approaches and preparation for kidney cancer ablation?
Kidney cancer ablation can be performed using two primary approaches: percutaneous and laparoscopic [1]. The percutaneous method is typically performed by interventional radiologists who insert a needle-like probe through a small puncture in the skin [1]. The laparoscopic approach, performed by urologists, involves small surgical incisions and the use of a camera to guide the probe [1]. Preparation for either method generally requires fasting and the temporary discontinuation of certain medications and supplements [1].
The Ablation Process
Anesthesia: Patients receive local anesthesia with sedation or general anesthesia depending on the approach [1].
Imaging Guidance: Real-time ultrasound, CT, or MRI scans are used to precisely locate the tumor [1].
Biopsy: A small sample of the tumor is often taken immediately before ablation for laboratory analysis [1].
Thermal Delivery: The probe is activated to freeze or heat the tumor, causing cell death [1].
Monitoring: Surgeons may place a temporary ureteral stent to protect the urinary tract from thermal damage [1].
What are the benefits and success rates of kidney cancer ablation?
The primary advantage of ablation over traditional surgery is the significant reduction in recovery time and physical trauma [1]. Studies have indicated that for small tumors, the five-year survival outcomes for ablation are comparable to those of surgical removal, but with fewer overall complications [1]. Patients often experience less pain, minimal scarring, and shorter hospital stays [1].
What are the risks and complications of kidney cancer ablation?
Kidney cancer ablation is generally safer than major surgery, but it can still cause bleeding, infection, organ damage, ureteral obstruction or treatment failure [1]. Complications are relatively rare but can occur depending on the tumor's proximity to vital structures.
Bleeding: Light bleeding at the insertion site or internal bruising.
Infection: A risk common to all invasive procedures [1], often managed with antibiotics.
Organ Damage: Rare injury to blood vessels, nerves, or nearby organs like the bowel.
Ureteral Obstruction: Potential blockage of the tube connecting the kidney to the bladder [1].
Treatment Failure: The possibility that some cancerous cells remain, requiring future monitoring or intervention [1].
What are recovery and long-term care like after kidney cancer ablation?
Recovery from kidney cancer ablation is remarkably swift compared to major abdominal surgery [1]. Most patients can return home within 24 hours and resume light activities such as driving and walking [1]. Strenuous exercise and heavy lifting should be avoided for several weeks to ensure proper internal healing. Long-term follow-up typically involves periodic imaging to ensure the tumor has been completely eradicated and has not returned.
Conclusion
Ablation for kidney cancer represents a significant advancement in oncology, providing a highly effective yet gentle treatment option for many patients. By prioritizing the preservation of kidney function and minimizing surgical risks, this procedure has become a standard of care for small renal masses. Patients are encouraged to consult with both a urologist and an interventional radiologist to explore the best personalized treatment strategy for their condition.
Frequently Asked Questions
1. Is kidney cancer ablation a major surgery?
No, ablation is typically considered a minimally invasive procedure. Depending on the approach, it may be performed as a minor surgical procedure or a percutaneous treatment.
2. How long does the procedure take?
The entire process, including preparation and the ablation itself, usually takes between one and three hours.
3. Can I have ablation if I have tumors in both kidneys?
Yes, ablation is an excellent option for patients with multiple small tumors or tumors in both kidneys, as it preserves as much healthy tissue as possible.
4. What is the maximum tumor size for ablation?
Ablation is generally most effective for tumors smaller than 3 centimeters (approximately 1.2 inches).
5. Will I need to stay in the hospital?
Many percutaneous ablations are performed on an outpatient basis, though some patients may stay for 24 hours for observation.
6. How soon can I drive after the procedure?
Most patients are cleared to drive and resume normal light activities within 24 hours, provided they are no longer taking sedative medications.
7. What is the difference between RFA and Cryoablation?
RFA uses heat from radio waves to kill cancer cells, while cryoablation uses extreme cold to freeze them. Both are effective, and the choice depends on tumor characteristics.
8. Is a biopsy performed during the ablation?
Yes, most providers perform a needle biopsy immediately before activating the ablation probe to confirm the tumor type.
9. When should I call my doctor after the procedure?
Contact your provider if you experience fever, excessive pain, trouble urinating, or signs of infection at the incision site.
10. Does ablation affect my kidney function?
One of the main benefits of ablation is that it causes minimal damage to healthy tissue, helping to maintain overall kidney function.
11. How do I prepare for kidney cancer ablation?
Follow your provider's specific instructions; depending on the type of ablation, you may need to avoid eating or drinking beforehand and stop some medications, vitamins or herbal supplements [1]. A ureteral stent may be placed to keep urine draining, because the temperature changes can cause urine to leak or block [1]. If you are treated as an outpatient you recover at the clinic and need someone to drive you home, while inpatient cases may stay about 24 hours, and most people resume normal activities such as walking and driving about a day later [1].
12. Does kidney cancer ablation hurt, and what anesthesia is used?
Laparoscopic ablation by a urologist is done under general anesthesia, while percutaneous ablation by an interventional radiologist uses local anesthesia to numb the skin, often with a sedative [1]. Afterward you may have some pain, fatigue, light bleeding and muscle soreness, which prescription or over-the-counter pain relievers can ease [1]. Overall, ablation offers a faster and less painful recovery than surgery [1].
Related Reading
Cryoablation: Uses, Procedure, Benefits and Risks explains cryoablation for tumors.
References
Cleveland Clinic. Ablation for Kidney Cancer: Procedure, Benefits & Outlook. Cleveland Clinic. Apr. 3, 2024. https://my.clevelandclinic.org/health/procedures/ablation-for-kidney-cancer
Talenfeld AD, Gennarelli RL, Elkin EB, et al. Percutaneous ablation versus partial and radical nephrectomy for T1a renal cancer: a population-based analysis. Ann Intern Med. 2018;169(2):69-77. PMID 29946703. https://doi.org/10.7326/M17-0585
Patel HD, Pierorazio PM, Johnson MH, et al. Renal functional outcomes after surgery, ablation, and active surveillance of localized renal tumors: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2017;12(7):1057-1069. PMID 28483780. https://doi.org/10.2215/CJN.11941116
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here.
Comments